Good afternoon, ladies and gentlemen. Bonjour à toutes et à tous.
Welcome to the 5th meeting of the Standing Committee on Industry, Science and Technology. We're hearing testimony from witnesses regarding Bill C-8.
We have before us, from the Canadian Chamber of Commerce, Scott Smith, who is director, intellectual property and innovation policy, and Lorne Lipkus, partner, Kestenberg Siegal Lipkus LLP, Canadian Intellectual Property Council; from the Canadian Generic Pharmaceutical Association, Jim Keon, president; from Food and Consumer Products Canada, Carla Ventin, vice-president, federal government affairs; and from Eaton Industries (Canada), Vladimir Gagachev, manager, regulatory affairs, electrical sector.
Thank you very much, ladies and gentlemen, for being with us. I understand that the clerk has advised you of the time limits for your testimony.
I need to ask the Canadian Chamber of Commerce if it is just one person who will be giving testimony today or if you are sharing your time.